Literature DB >> 8569213

Vasodilatory effect of nicorandil on coronary arterial microvessels: its dependency on vessel size and the involvement of the ATP-sensitive potassium channels.

K Akai1, Y Wang, K Sato, N Sekiguchi, A Sugimura, T Kumagai, T Komaru, H Kanatsuka, K Shirato.   

Abstract

We aimed to clarify the size dependency of nicorandil-induced dilation in coronary microcirculation and the involvement of adenosine triphosphate (ATP)-sensitive potassium channels. Coronary arterial microvessels were observed through a microscope equipped with a floating objective in anesthetized open-chest dogs (n = 29). Heart rate and mean aortic pressure were maintained at control level. In 16 dogs, nicorandil was infused into the coronary in a cumulative fashion (0.1, 1.0, 10, and 100 micrograms/kg/min, for 5 min for each dose). In 13 dogs, glibenclamide (10 microM) was topically applied onto the observed area, and nicorandil was similarly infused. Nicorandil dilated vessels < 100 microns in diameter at all applied doses in a dose-dependent manner. Glibenclamide abolished the dilation of these vessels at the lower two doses. Vessels > 100 microns in diameter dilated only at the two higher doses and the dilation was not affected by glibenclamide. These data suggest that the vessels < 100 microns are more sensitive to this agent than other size vessels, and that ATP-sensitive potassium channels are involved in the nicorandil-induced dilation of vessels smaller than 100 microns, whereas the dilation of other size vessels occurs independently of this channel.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8569213     DOI: 10.1097/00005344-199510000-00006

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  25 in total

Review 1.  KATP Channels in the Cardiovascular System.

Authors:  Monique N Foster; William A Coetzee
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

2.  Intravenous nicorandil versus adenosine for fractional flow reserve measurement: a crossover, randomized study.

Authors:  Takeshi Nishi; Hideki Kitahara; Yoshihide Fujimoto; Takashi Nakayama; Kengo Nagashima; Hideki Hanaoka; Yoshio Kobayashi
Journal:  Heart Vessels       Date:  2018-06-01       Impact factor: 2.037

3.  Takotsubo cardiomyopathy in two patients with microvascular angina.

Authors:  Hiroshi Takahashi; Shigemasa Tani; Kimio Kikushima; Shingo Furuya; Kiyoshi Iida; Naoya Matsumoto; Atsushi Hirayama
Journal:  J Cardiol Cases       Date:  2015-05-02

Review 4.  The Role of Nitroglycerin and Other Nitrogen Oxides in Cardiovascular Therapeutics.

Authors:  Sanjay Divakaran; Joseph Loscalzo
Journal:  J Am Coll Cardiol       Date:  2017-11-07       Impact factor: 24.094

Review 5.  Nicorandil and Long-acting Nitrates: Vasodilator Therapies for the Management of Chronic Stable Angina Pectoris.

Authors:  Jason M Tarkin; Juan Carlos Kaski
Journal:  Eur Cardiol       Date:  2018-08

6.  Intracoronary administration of anisodamine and nicorandil in individuals undergoing primary percutaneous coronary intervention for acute inferior myocardial infarction: A randomized factorial trial.

Authors:  Chunhong Chen; Xianghua Fu; Wei Li; Xinwei Jia; Shiru Bai; Wei Geng; Kun Xing
Journal:  Exp Ther Med       Date:  2015-07-07       Impact factor: 2.447

Review 7.  Use of nicorandil in cardiovascular disease and its optimization.

Authors:  Shigeo Horinaka
Journal:  Drugs       Date:  2011-06-18       Impact factor: 9.546

Review 8.  Multiplicity of effectors of the cardioprotective agent, diazoxide.

Authors:  William A Coetzee
Journal:  Pharmacol Ther       Date:  2013-06-19       Impact factor: 12.310

9.  Nicorandil increased the cerebral blood flow via nitric oxide pathway and ATP-sensitive potassium channel opening in mice.

Authors:  Masakazu Kotoda; Tadahiko Ishiyama; Kazuha Mitsui; Sohei Hishiyama; Takashi Matsukawa
Journal:  J Anesth       Date:  2018-03-05       Impact factor: 2.078

10.  Pharmacological prevention of peri-, and post-procedural myocardial injury in percutaneous coronary intervention.

Authors:  Hideki Ishii; Tetsuya Amano; Tatsuaki Matsubara; Toyoaki Murohara
Journal:  Curr Cardiol Rev       Date:  2008-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.